The Capitalist Countdown is a weekly series that features the biggest stories from the market’s hottest stocks as well as news from under-the-radar hidden gems capable of delivering mutibagger returns to your portfolio.
Please sit back, relax and enjoy Capitalist Countdown’s top 5 market-moving news stories for the week of November 7th – 13th, 2022.
By the Time We Enter 2023, the World Should Finally Shrug off the COVID-19 Pandemic and Return to “Normal”
Supply chains should improve, and the increased availability of goods should slow down rising prices, increasing consumer spending. One of the industries expected to undergo significant growth over the coming years is the health and beauty industry, which has a projected CAGR of nearly 5% through 2025. Below are four stocks, each with its own unique approach to the health and beauty industry, that investors should consider for superior potential returns in 2023.
One Would Be Hard-Pressed to Find a Tech Company That Isn’t Struggling to Grow Revenues and Control Costs
Big tech firms that rely on advertising revenue, mainly social media companies, such as Meta Platforms (NASDAQ: META), have been hit particularly hard due to companies slashing their advertising budgets.
When You Are the Largest Shareholder of a Company, Like Tesla’s CEO Elon Musk and the Board of Directors is Made Up of Friends, it Can Be Easy to Give Yourself a Raise, Whether You Deserve it or Not
When the extra payday comes in the form of stock options instead of a paycheck, it’s even easier to push a lavish raise through. However, Elon Musk’s $56 billion Tesla (NASDAQ: TSLA) stock option grant is clearly pushing the limits, and he’ll be forced to defend the largest payday in corporate history as he makes his way back into the courtroom.
With the COVID-19 Pandemic Changing the World as We Know it Over the Last Two Years, the Critical Part the Biotechnology Industry Plays in Our Everyday Lives Has Become Apparent to Even the Casual Observer
Companies like Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) became household names thanks to their successful COVID-19 vaccines. As we head into the second half of 2022, here are five Biotech Stocks that investors should pay attention to for the rest of the year.
The U.S. Stock Market Soared Today in Response to the Better-Than-Expected October Inflation Report
The newly released Consumer Price Index (CPI) report, used as a gauge to track Inflation, increased 0.4% month-over-month and 7.7% from last year. The inflation data marks its lowest yearly increase since January 2022 and a deceleration of last month’s 8.2%. According to Dow Jones, economists projected a rise of 0.6% and 7.9%. The NASDAQ Composite (NASX), S&P 500 (SPX) and Dow Jones (DJIA) had their best day in two years, rising +7.3%, +5.5% and +3.7%, respectively. Tech Stocks, which rising inflation has hit the hardest, soared back to life today, with top names such as Amazon (NASDAQ: AMZN) +12%, Meta (NASDAQ: META) +10%, Microsoft (NASDAQ: MSFT) +8%, Apple (NASDAQ: AAPL) +8% and Tesla (NASDAQ: TSLA) +7% leading the charge.